Miller Mary — SEC insider filings

SEC reporting owner CIK 1841088. 40 insider filings on record with FilingPulse; latest filed 2026-11-19.

Transaction summary — filings shown

Covers all 40 filings on record, filed 2021-02-16 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Butterfly Network, Inc. (BFLY)General Counsel & Corp Sec5—1 leg · 16,677 sh · $99,2535
Acrivon Therapeutics, Inc. (ACRV)Chief Legal Officer35—5 legs · 1,758 sh · $3,18931

Insider filings — Miller Mary

FiledFormIssuerReported transactionsSource
2026-11-194Acrivon Therapeutics, Inc. (ACRV)Sale (S): 193 @ $1.45EDGAR
2026-10-264Acrivon Therapeutics, Inc. (ACRV)Sale (S): 513 @ $1.84EDGAR
2026-10-074Acrivon Therapeutics, Inc. (ACRV)Sale (S): 294 @ $1.99EDGAR
2026-08-204Acrivon Therapeutics, Inc. (ACRV)Sale (S): 185 @ $2.01EDGAR
2026-07-234Acrivon Therapeutics, Inc. (ACRV)Sale (S): 573 @ $1.76EDGAR
2026-05-204Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 49,830 @ $0EDGAR
2026-05-184Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 184 @ $1.92EDGAR
2026-04-214Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 558 @ $1.78EDGAR
2026-03-034Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 129,760 (derivative) @ $0EDGAR
2026-02-184Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 217 @ $1.63EDGAR
2026-01-214Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 659 @ $1.98EDGAR
2025-11-184Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 184 @ $2.24EDGAR
2025-10-214Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 558 @ $1.81EDGAR
2025-10-034Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 284 @ $1.81EDGAR
2025-08-184Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 184 @ $1.39EDGAR
2025-07-214Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 558 @ $1.32EDGAR
2025-05-164Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 184 @ $1.14EDGAR
2025-04-184Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 558 @ $1.81EDGAR
2025-04-034Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 15,616 (derivative) @ $0EDGAR
2025-03-044Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 93,693 (derivative) @ $0EDGAR
2025-02-194Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 217 @ $5.42EDGAR
2025-01-224Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 659 @ $5.78EDGAR
2024-11-274Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 67,567 (derivative) @ $0EDGAR
2024-11-184Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 184 @ $7.92EDGAR
2024-10-214Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 558 @ $7.87EDGAR
2024-10-034Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 284 @ $6.98EDGAR
2024-08-164Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 184 @ $7.02EDGAR
2024-07-194Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 558 @ $7.69EDGAR
2024-05-164Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 184 @ $8.36EDGAR
2024-04-194Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 558 @ $10.34EDGAR
2024-02-164Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 217 @ $3.40EDGAR
2024-01-194Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 652 @ $4.35EDGAR
2023-11-164Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 735 @ $5.08EDGAR
2023-10-194Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 2,232 @ $5.48EDGAR
2023-09-284Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 3,858 @ $0 · Grant/award (A): 11,576 (derivative) @ $0EDGAR
2022-03-244Butterfly Network, Inc. (BFLY)Grant/award (A): 54,789 @ $0EDGAR
2022-03-084Butterfly Network, Inc. (BFLY)Grant/award (A): 189,655 @ $0EDGAR
2022-02-174Butterfly Network, Inc. (BFLY)Sale (S): 16,677 @ $5.95EDGAR
2021-02-254/AButterfly Network, Inc. (BFLY)Grant/award (A): 155,745 · Grant/award (A): 259,575 (derivative)EDGAR
2021-02-164Butterfly Network, Inc. (BFLY)Grant/award (A): 259,575 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1841088 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs